Nuvo Pharmaceuticals, a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, signed definitive, binding purchase agreements with Aralez Pharmaceuticals to acquire a portfolio of more than 20 revenue-generating products, as well as the associated personnel and infrastructure to continue the products’ management and growth (the Proposed Transaction or the Transaction). Upon closing…
Nuvo Pharmaceuticals Intends To Acquire Commercial Products And Infrastructure From Aralez Pharmaceuticals
Nuvo Pharmaceuticals Inc., a healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced the signing of a letter of intent with Aralez Pharmaceuticals Inc. to acquire a portfolio of more than 20 revenue-generating products, as well as the associated personnel and infrastructure to continue the products’ management and growth (the…
Nuvo Pharmaceuticals Picks Up Topical Head Lice Treatment In U.S.
Nuvo Pharmaceuticals (Ireland) Limited acquires U.S. product rights to Resultz from Piedmont Pharmaceuticals LLC. Nuvo Pharmaceuticals Inc., a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that its wholly owned subsidiary, Nuvo Pharmaceuticals (Ireland) Limited has acquired the U.S. rights to Resultz (50% isopropyl myristate, 50% cyclomethicone D5 topical solution…